A new study of the British population shows that antibodies in the human body fighting COVID-19 declined rapidly in the British population during the summer, suggesting any immunity against the virus may not last long.The study, conducted by Imperial College London and published Tuesday, involved tests on more than 365,000 British people between June 20 and Sept. 28.In their findings, the researchers’ analysis of the home finger-prick tests found that the number of people testing positive for antibodies dropped by 26.5% during the study period, from almost 6% to 4.4%.The findings suggest the possibility of decreasing population immunity ahead of a second wave of infections in recent weeks that has forced local lockdowns and restrictions.The researchers say it is unclear what level of protection antibodies give a person against COVID-19 specifically.Imperial College London Department of Infectious Disease head, Wendy Barclay, told reporters in London they are confident in what a decline in antibodies tells them.“On the balance of evidence, I would say with what we know for other coronaviruses, it would look as if immunity declines away at the same rate as antibodies decline away, and that this is an indication of waning immunity at the population level.”The researchers say that more than anything, the study reinforces the need for a vaccine to effectively bring the virus under control.
…
Day: October 27, 2020
U.S. government researchers say an experimental COVID-19 therapeutic drug is not effective at treating patients hospitalized with an advanced stage of the novel coronavirus. The National Institute of Allergy and Infectious Diseases issued a statement Monday saying it would no longer recruit new patients to take part in a clinical trial of the experimental drug, called bamlanivimab. The drug, developed by U.S.-based drugmaker Eli Lilly and Canadian-based biotech firm AbCellera, is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight off the virus. The antibody therapy was similar to one given to U.S. President Donald Trump after he tested positive for COVID-19 earlier this month. The clinical trial was paused earlier this month by independent monitors because of safety concerns. The study, which launched in August, aimed to enroll 10,000 hospitalized coronavirus patients in the United States. Eli Lilly has already applied to the U.S. Food and Drug Administration for emergency authorization for the drug to be used for mild to moderate cases of COVID-19 infections based on preliminary results from a different clinical trial. The United States is in the midst of a dramatic surge of new COVID-19 cases, with more than 66,000 confirmed on Monday, according to data released by the FILE PHOTO: Healthcare worker carries specimen collection tubes at COVID-19 drive-in testing location in Houston, Texas.In the western state of Utah, a group representing the state’s hospitals have warned Gov. Gary Herbert that the facilities are reaching the point where they may have to start rationing care, where doctors would have to determine who could remain in the hospital based on factors such as age and overall health. The situation is steadily improving in Melbourne, Australia’s second-largest city, which posted a second consecutive day Tuesday with no new coronavirus infections. The initial milestone on Monday was the first COVID-19-free day since June 9. Melbourne and the state of Victoria had been plagued by a massive spike of new coronavirus cases, peaking in August when daily new cases rose above 700. The resurgence of new cases has been blamed on security lapses at hotels where travelers were being quarantined after arriving from overseas. Victoria state Premier Daniel Andrews announced Monday that Melbourne’s five million citizens will be able to leave their homes effective Tuesday at midnight, and that all cafes, restaurants, bars, shops and hotels will be allowed to reopen.
…
Disinfecting public spaces is a major undertaking but it is essential for a safe return to normal activity. Now an army of robots that uses ultra-violet light to disinfect surfaces and the air, as Matt Dibble reports.
Camera, Producer: Matt Dibble
…
Russian authorities issued a national mask requirement Tuesday as the country set a single day record for coronavirus deaths amid a resurgence of new cases.Health officials reported 16,550 new cases and 320 new deaths Tuesday, the highest daily death toll since the pandemic started.In response, Russia’s consumer safety and public health agency, Rospotrebnadzor, ordered all Russians to wear masks in crowded public spaces, on public transit, in taxis, parking lots and elevators starting on Wednesday.The agency also recommends regional authorities put a curfew on entertainment events, cafes, restaurants and bars from 11 p.m. to 6 a.m.Russia has the world’s fourth largest tally of more than 1.5 million confirmed cases, according to the Johns Hopkins University, which is tracking the pandemic.The government’s coronavirus task force has been reporting more than 15,000 new infections every day since Sunday, which is much higher than in spring.Russia has reported more than 26,000 virus-related deaths.Despite the sharp spike in daily infections, Russian authorities have repeatedly dismissed the idea of imposing a second national lockdown or shutting down businesses.Most virus-related restrictions were lifted in July as cases dropped, but masks were still encouraged.
…
U.S. government researchers say an experimental COVID-19 therapeutic drug is not effective at treating patients hospitalized with an advanced stage of the novel coronavirus. The National Institute of Allergy and Infectious Diseases issued a statement Monday saying it would no longer recruit new patients to take part in a clinical trial of the experimental drug, called bamlanivimab. The drug, developed by U.S.-based drugmaker Eli Lilly and Canadian-based biotech firm AbCellera, is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight off the virus. The antibody therapy was similar to one given to U.S. President Donald Trump after he tested positive for COVID-19 earlier this month. The clinical trial was paused earlier this month by independent monitors because of safety concerns. The study, which launched in August, aimed to enroll 10,000 hospitalized coronavirus patients in the United States. Eli Lilly has already applied to the U.S. Food and Drug Administration for emergency authorization for the drug to be used for mild to moderate cases of COVID-19 infections based on preliminary results from a different clinical trial. The United States is in the midst of a dramatic surge of new COVID-19 cases, with more than 66,000 confirmed on Monday, according to data released by the FILE PHOTO: Healthcare worker carries specimen collection tubes at COVID-19 drive-in testing location in Houston, Texas.In the western state of Utah, a group representing the state’s hospitals have warned Gov. Gary Herbert that the facilities are reaching the point where they may have to start rationing care, where doctors would have to determine who could remain in the hospital based on factors such as age and overall health. The situation is steadily improving in Melbourne, Australia’s second-largest city, which posted a second consecutive day Tuesday with no new coronavirus infections. The initial milestone on Monday was the first COVID-19-free day since June 9. Melbourne and the state of Victoria had been plagued by a massive spike of new coronavirus cases, peaking in August when daily new cases rose above 700. The resurgence of new cases has been blamed on security lapses at hotels where travelers were being quarantined after arriving from overseas. Victoria state Premier Daniel Andrews announced Monday that Melbourne’s five million citizens will be able to leave their homes effective Tuesday at midnight, and that all cafes, restaurants, bars, shops and hotels will be allowed to reopen.
…
Hurricane Zeta pounded Mexico’s northern Yucatan Peninsula with strong winds and heavy rains late Monday into Tuesday. The U.S.-based National Hurricane Center said Zeta made landfall north of Tulum with maximum sustained winds of 130 kilometers per hour. A hurricane warning is posted for the resort island of Cozumel, and from Punta Allen to Progreso, Mexico. People in the Mexican resort city of Cancun are also bracing for Hurricane Zeta. Forecasters say Zeta is expected to regain strength Tuesday as it moves into the Southern Gulf of Mexico on a northerly pattern toward the United States, where a hurricane watch is in effect for the metropolitan New Orleans area and Morgan City, Louisiana, east to the Mississippi-Alabama border. People in the U.S. central Gulf Coast will begin seeing the effects of Zeta by Tuesday night before the storm moves inland toward Georgia Wednesday then into the southern Appalachians Wednesday night and the Mid-Atlantic region on Thursday. Zeta is the second storm to strike Mexico this month. Hurricane Delta hit the Yucatan Peninsula in early October, downing trees and knocking out power to thousands but no reported deaths. Hurricane Delta also made landfall in the U.S. Gulf coast state of Louisiana, where Hurricane Laura hit in late August, killing at least six people.
…